These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


118 related items for PubMed ID: 6327902

  • 1. Comparative immunogenicity studies on Epstein-Barr virus membrane antigen (MA) gp340 with novel adjuvants in mice, rabbits, and cotton-top tamarins.
    Morgan AJ, Epstein MA, North JR.
    J Med Virol; 1984; 13(3):281-92. PubMed ID: 6327902
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human use.
    Morgan AJ, Allison AC, Finerty S, Scullion FT, Byars NE, Epstein MA.
    J Med Virol; 1989 Sep; 29(1):74-8. PubMed ID: 2555448
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cottontop tamarins against EB virus-induced malignant lymphomas.
    Morgan AJ, Mackett M, Finerty S, Arrand JR, Scullion FT, Epstein MA.
    J Med Virol; 1988 Jun; 25(2):189-95. PubMed ID: 2839612
    [Abstract] [Full Text] [Related]

  • 7. Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes.
    North JR, Morgan AJ, Thompson JL, Epstein MA.
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7504-8. PubMed ID: 6296836
    [Abstract] [Full Text] [Related]

  • 8. Prevention of Epstein-Barr (EB) virus-induced lymphoma in cottontop tamarins by vaccination with the EB virus envelope glycoprotein gp340 incorporated into immune-stimulating complexes.
    Morgan AJ, Finerty S, Lovgren K, Scullion FT, Morein B.
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2093-6. PubMed ID: 2841417
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The major Epstein-Barr virus (EBV) envelope glycoprotein gp340 when incorporated into Iscoms primes cytotoxic T-cell responses directed against EBV lymphoblastoid cell lines.
    Wilson AD, Lövgren-Bengtsson K, Villacres-Ericsson M, Morein B, Morgan AJ.
    Vaccine; 1999 Mar 05; 17(9-10):1282-90. PubMed ID: 10195641
    [Abstract] [Full Text] [Related]

  • 12. Vaccination against Epstein-Barr virus: current progress and future strategies.
    Epstein MA.
    Lancet; 1986 Jun 21; 1(8495):1425-7. PubMed ID: 2872525
    [Abstract] [Full Text] [Related]

  • 13. In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340.
    Ulaeto D, Wallace L, Morgan A, Morein B, Rickinson AB.
    Eur J Immunol; 1988 Nov 21; 18(11):1689-97. PubMed ID: 2904885
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin.
    Ragot T, Finerty S, Watkins PE, Perricaudet M, Morgan AJ.
    J Gen Virol; 1993 Mar 21; 74 ( Pt 3)():501-7. PubMed ID: 8383183
    [Abstract] [Full Text] [Related]

  • 18. Large-scale purification of Epstein-Barr virus membrane antigen gp340 with a monoclonal antibody immunoabsorbent.
    Randle BJ, Morgan AJ, Stripp SA, Epstein MA.
    J Immunol Methods; 1985 Feb 28; 77(1):25-36. PubMed ID: 2579161
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.